Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Prestwick3_000257

Client Email

Product

Prestwick3_000257
US Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Prestwick3_000257

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 13 USDMF, 5 CEP/COS, 2 JDMF, 1 EU WC, 3 KDMF, 19 NDC API, 13 Listed Suppliers, $ API Reference Price

23 API Suppliers
13 USDMF
5 CEP/COS
2 JDMF
1 EU WC
3 KDMF
19 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

97 FDF Dossiers, 48 FDA Orange Book, 13 Europe, 10 Canada, 9 South Africa, 17 Listed Dossiers

97 FDF Dossiers
48 FDA Orange Book
13 Europe
10 Canada
9 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.05%, GEL;TOPICAL - 0.025%, GEL;TOPICAL - 0.01%, CREAM;TOPICAL - 0.025%, GEL;TOPICAL - 0.04%, GEL;TOPICAL - 0.06%, GEL;TOPICAL - 0.08%, GEL;TOPICAL - 0.1%, CREAM;TOPICAL - 0.01%;4%;0.05%, GEL;TOPICAL - 0.05%, GEL;TOPICAL - 1.2%;0.025%

CREAM;TOPICAL - 0.1%
CREAM;TOPICAL - 0.05%
GEL;TOPICAL - 0.025%
GEL;TOPICAL - 0.01%
CREAM;TOPICAL - 0.025%
GEL;TOPICAL - 0.04%
GEL;TOPICAL - 0.06%
GEL;TOPICAL - 0.08%
GEL;TOPICAL - 0.1%
CREAM;TOPICAL - 0.01%;4%;0.05%
GEL;TOPICAL - 0.05%
GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 3 SPI Pharma, 19 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 16 BASF, 1 BioSpectra, 6 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 8 Kerry, 3 Lonza Capsugel, 5 Lubrizol Life Science Health, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 1 Qualicaps, 11 Roquette, 9 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

2 Rochem International Inc
3 SPI Pharma
19 DKSH
1 Jai Radhe Sales
1 Pharm-RX Chemical
2 Gangwal Healthcare
10 Nanjing Well Pharmaceutical
1 Pfanstiehl
4 ACG Worldwide
7 Actylis
1 Aeon Procare
16 BASF
1 BioSpectra
6 Corel Pharma Chem
2 Finar
5 Gangwal Chemicals
8 Kerry
3 Lonza Capsugel
5 Lubrizol Life Science Health
2 Microlex e.U
1 Nanjing Bold Chemical
1 Pluviaendo
1 Qualicaps
11 Roquette
9 Seppic
2 Shandong Focus Biotechnology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Valens Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Topical, 23 Thickeners and Stabilizers, 23 Solubilizers, 19 Parenteral, 17 Fillers, Diluents & Binders, 15 Film Formers & Plasticizers, 13 Coating Systems & Additives, 11 Emulsifying Agents, 9 Controlled & Modified Release, 8 Co-Processed Excipients, 8 Empty Capsules, 7 Direct Compression, 6 Lubricants & Glidants, 5 Taste Masking, 5 Surfactant & Foaming Agents, 4 Granulation, 3 Coloring Agents, 3 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 API Stability Enhancers, 1 Soft Gelatin

40 Topical
23 Thickeners and Stabilizers
23 Solubilizers
19 Parenteral
17 Fillers, Diluents & Binders
15 Film Formers & Plasticizers
13 Coating Systems & Additives
11 Emulsifying Agents
9 Controlled & Modified Release
8 Co-Processed Excipients
8 Empty Capsules
7 Direct Compression
6 Lubricants & Glidants
5 Taste Masking
5 Surfactant & Foaming Agents
4 Granulation
3 Coloring Agents
3 Rheology Modifiers
2 Chewable & Orodispersible Aids
2 API Stability Enhancers
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 23 Finished Drug Prices

5 US Medicaid Prescriptions
23 Finished Drug Prices

MARKET PLACE

29 APIs, 7 FDF Dossiers

29 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 2 US Exclusivities

7 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 1,929 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 2DOW PHARM

02 6GALDERMA LABS LP

filter Patent Number Reset all filters

8 All

01 18617580

02 19868103

03 110420743

04 110653656

05 110653899

06 111071878

07 111324710

08 112053546

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 6Y

02 2Blank

filter Expiration Date Reset all filters

8 All

01 12028-02-03

02 12028-08-08

03 22030-12-30

04 12032-06-29

05 12038-07-12

06 22038-08-22

US Patents
US Exclusivities

Product Main Page

01

DOW PHARM

Formnext Forum

Not Confirmed

DOW PHARM

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-22

US Patent Number : 10653656

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209353

Patent Use Code : U-2368

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

DOW PHARM

Formnext Forum

Not Confirmed

DOW PHARM

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-08-22

US Patent Number : 11324710

Drug Substance Claim :

Drug Product Claim :

Application Number : 209353

Patent Use Code : U-2368

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-08-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GALDERMA LABS LP

BENZOYL PEROXIDE; TRETINOIN

Formnext Forum

Not Confirmed

GALDERMA LABS LP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-08-08

BENZOYL PEROXIDE; TRETINOIN

US Patent Number : 9868103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214902

Patent Use Code : U-3194

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GALDERMA LABS LP

BENZOYL PEROXIDE; TRETINOIN

Formnext Forum

Not Confirmed

GALDERMA LABS LP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-07-12

BENZOYL PEROXIDE; TRETINOIN

US Patent Number : 10420743

Drug Substance Claim :

Drug Product Claim :

Application Number : 214902

Patent Use Code : U-3194

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-07-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GALDERMA LABS LP

BENZOYL PEROXIDE; TRETINOIN

Formnext Forum

Not Confirmed

GALDERMA LABS LP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-12-30

BENZOYL PEROXIDE; TRETINOIN

US Patent Number : 10653899

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214902

Patent Use Code : U-3194

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GALDERMA LABS LP

BENZOYL PEROXIDE; TRETINOIN

Formnext Forum

Not Confirmed

GALDERMA LABS LP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-06-29

BENZOYL PEROXIDE; TRETINOIN

US Patent Number : 12053546

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214902

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GALDERMA LABS LP

BENZOYL PEROXIDE; TRETINOIN

Formnext Forum

Not Confirmed

GALDERMA LABS LP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

BENZOYL PEROXIDE; TRETINOIN

US Patent Number : 8617580

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214902

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GALDERMA LABS LP

BENZOYL PEROXIDE; TRETINOIN

Formnext Forum

Not Confirmed

GALDERMA LABS LP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-12-30

BENZOYL PEROXIDE; TRETINOIN

US Patent Number : 11071878

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214902

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?